|
发表于 2009-8-20 06:40 PM
|
显示全部楼层
这股票是不是用dollar average比较靠谱些啊?除非你有insider news。
jc200900 发表于 2009-8-20 18:57 
what do you mean by "用dollar average"
Following is post from Kutz, he suggested this stock on Aug 3rd before Aug 11 data release. There's no doubt the data released is very good. The only concern here is it could take months for AVNR to clear the old complete response letter and then another few months for FDA to make decision. During the interim, the company might need some more cash. But again, the great data already reduce the risk of holding the stock a lot, there's no investment risk free. According to Beacon Equity report
http://finance.yahoo.com/news/Be ... 2.html?x=0&.v=2
" the market for AVNR's drug candidate Zenvia could reach $500 million to more than $1 billion at its market saturation. Zenvia is in phase III clinical trials, with the prospects of reaching commercialization reaching approximately 90% following successful completion of this phase of development. "
Disclaimer,
You need to do your own DD to make investment decision, I am holding Long position of the stock so my comment might biased.
===================
Its about AVNR and upcoming top-line/bottom-line results for the P3 STAR study using Zeniva in PBA for MS and ALS patients. Good numbers would likely mean a nice PPS rise as this PBA indication does not have a treatment!
They are running the "STAR" and the blined protion is completing and rolling patients into a open-label extension and the majority have agreed to roll (usually a good sign)! The primary/secondary efficacy data will be reported later this month.
The study is being done under an SPA agreement with the FDA off an old complete response letter that was then called an approvable letter.
AVNR has a sorted history (I am aware of most of it in the last 5 years) and Zeniva has other applications on hold because they are cash short, but I am thinking of playing this data reporting as a trade as I also consider an entry into ACOR for MS affliction itself.
Anybody following this lately and has something to cough up would be appreciated as well as a chart view?
we ain't making it in ACUS-got to make it somewhere?
best regards
Kutz |
|